Form 4: Organogenesis Holdings Inc. CFO Reports Stock Disposals

David Francisco, CFO of Organogenesis Holdings Inc., reports the disposal of Class A Common Stock to cover tax obligations.

Summary

• David Francisco, the Chief Financial Officer of Organogenesis Holdings Inc., filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the disposal of Class A Common Stock on multiple dates: February 15, 2025, and February 16, 2025.
• These transactions were likely to cover tax obligations, as indicated by transaction code 'F'.
• The price for the disposed shares was $3.7.
• Following these transactions, Francisco directly owns 393,939 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, ensuring transparency and compliance with securities regulations.

Stakeholder Impact

• The disposal of shares by the CFO could have a minor impact on shareholder sentiment, although such transactions are common and often anticipated.

Key Dates

Keywords

Form 4, Beneficial Ownership, Organogenesis Holdings Inc., ORGO, David Francisco, CFO, Stock Disposal, Class A Common Stock